Provided by Tiger Fintech (Singapore) Pte. Ltd.

Tourmaline Bio

16.76
+0.75004.68%
Post-market: 16.760.00000.00%17:18 EDT
Volume:439.15K
Turnover:7.32M
Market Cap:430.49M
PE:-5.80
High:17.20
Open:15.84
Low:15.49
Close:16.01
Loading ...

Tourmaline Bio price target lowered to $63 from $74 at Truist

TIPRANKS
·
10 Apr

Truist Cuts Price Target on Tourmaline Bio to $63 From $74, Keeps Buy Rating

MT Newswires Live
·
10 Apr

Tourmaline Bio Inc : Truist Securities Cuts Target Price to $63 From $74

THOMSON REUTERS
·
10 Apr

Truist biotech analyst holds an analyst/industry conference call

TIPRANKS
·
02 Apr

Tourmaline Bio’s TOUR006: Potential Best-in-Class IL-6 Treatment with Strategic Market Positioning

TIPRANKS
·
27 Mar

Tourmaline Bio Inc reports results for the quarter ended December 31 - Earnings Summary

Reuters
·
17 Mar

Positive Buy Rating for Tourmaline Bio Driven by Promising Pacibekitug Developments and Strategic Value

TIPRANKS
·
17 Mar

Tourmaline Bio (TRML) Gets a Buy from Wedbush

TIPRANKS
·
14 Mar

Truist Financial Sticks to Their Buy Rating for Tourmaline Bio (TRML)

TIPRANKS
·
14 Mar

Wedbush Lifts Price Target on Tourmaline Bio to $43 From $42, Keeps Outperform Rating

MT Newswires Live
·
14 Mar

Tourmaline Bio Is Maintained at Buy by HC Wainwright & Co.

Dow Jones
·
14 Mar

Tourmaline Bio’s Promising Clinical Trials and Financial Outlook Justify Buy Rating

TIPRANKS
·
14 Mar

Tourmaline Bio price target raised to $50 from $49 at H.C. Wainwright

TIPRANKS
·
14 Mar

Tourmaline Bio, Inc. : H.c. Wainwright Raises Target Price to $50 From $49

THOMSON REUTERS
·
14 Mar

Tourmaline Bio’s 2024 Financial Results and Strategic Advances

TIPRANKS
·
14 Mar

Tourmaline Bio: Strong Financials and Promising Pipeline Drive Buy Rating

TIPRANKS
·
14 Mar

Tourmaline Bio Q4 2024 GAAP EPS $(0.86) Beats $(0.88) Estimate, Cash Balance Of $294.9M As Of December 31, Providing Expected Runway Into The Second Half Of 2027

Benzinga
·
13 Mar

BRIEF-Tourmaline Bio's cash position to provide cash runway into second half of 2027

Reuters
·
13 Mar

Tourmaline Bio reports Q4 EPS (86c), consensus (87c)

TIPRANKS
·
13 Mar

Tourmaline Bio sees cash runway into 2H27

TIPRANKS
·
13 Mar